Preventive Medicine Is Not Theory. Israel Is Making It Work.

News and Insights

Preventive Medicine Is Not Theory. Israel Is Making It Work.

May 12, 2026

Prevention requires more than technology. It demands alignment across data, incentives, and care delivery. Israel offers a working blueprint.

There are various reasons why Israelis are not complacent about new ideas and change. It could be the pioneering spirit that founded and built the country. It might be the relative "youthfulness" of the country, having just celebrated its 78^th birthday. Or perhaps it is something intellectually and operationally bigger.

It may be that Israel, the same nation and people that made the desert bloom, is threatened by proxy-funded terrorism, faces a lack of rain half the year, and lacks the oil that its neighbors have to fund their futures, simply does not have time, resources or the comfort of peace to take for granted the status quo.

This permeates all aspects of life, and it may be most apparent in the country's approach to health-care delivery and innovation. In its infancy, Israel created a national health system that ensured access to care for all. In that unity, ideas and innovations could be rapidly applied.

In contrast, the world's largest health system - the United States - was built to treat illness, not to prevent it. Despite advances in diagnostics, AI and genomics, the most developed nation's systems wait for disease to appear and then commit to care.

In Israel, the application paradigm is different. Disease is expensive. Health, albeit an investment, is good medicine and good business.

Israel's health system, anchored by integrated providers, longitudinal patient records and a culture of rapid adoption, is increasingly oriented around predicting disease before it evolves into serious illness.

Care and cost are social catalysts. Innovation is the foundation for implementation. Israel's instinct is to lean into applying early detection and predictive care as a national primary health delivery and access strategy - not an afterthought.

The country's decades of digitized, integrated health data mean providers can track patients across their entire life journeys. Layer on AI and predictive analytics, and the system begins to surface risk patterns in cardiovascular, metabolic and oncology, to give a few examples, well before symptoms emerge. The result is a gradual and meaningful shift: from episodic care - that may "miss" the presentation of disease - to continuous health management.

Preventive medicine, in this model, is not wishful thinking. It is an operational reality.

Contrast this with the United States.

The U.S. leads the world in medical innovation, yet its system remains structurally anchored in symptomatic treatment. In a fee-for-service structure, where care is economically sustained by patient volume, treatment takes priority over prevention. Data is fragmented across providers, payers and varied platforms. Even when predictive tools exist, they are difficult to deploy at scale because no single entity is accountable for assessing and engaging the patient health journey.

Even for life science companies seeking to deploy the wealth of data to develop and refine new therapies that sustain and save lives, mining and applying it is arduous, expensive, and laden with cybersecurity concerns.

The vision of value-based care - a system that rewards health systems for keeping people well - bows to the current, easier-to-track economic approach of paying for "what was done" to the patient rather than sustaining well-being. The issue is not a lack of technology. It is a lack of organizational and data alignment.

Which raises a more productive question:

If the U.S. decides it wants to catch up, can Israel be the partner to help it get there?

Many Israeli companies are already selling ideas, services, and AI tools into the U.S. health system. Yet, they are required to navigate a system that is not structured for prevention. In the countless conversations I've had with Israeli entrepreneurs, they often face an uphill climb, system by system, from U.S. health sector leaders.

"Don't they understand it will save money and help diagnose disease earlier, improving national health?"

The answer is that they absolutely do, but there is an operational barrier to making the shift, even as policy increasingly focuses on preventive care.

So how can Israeli innovators help U.S. health counterparts? Also, by doing so, how can they pave the way for greater traction in the world's largest single health market?

What Israel has built is not just a set of tools. It is a working model of how preventive care can function at scale:

• Integrated data across the patient lifecycle
• Alignment between payers, providers and patients
• Rapid deployment of innovation into clinical workflows
• A system-level incentive to keep populations healthy

These are not easily replicated, especially for a system as massive and fragmented as the U.S. But they are successful and models that can be informative, even if, for now, they are aspirational.

Let's take the first item on the list: Integrated data across the patient lifecycle.

The U.S. system is not close to fully integrating patient data or tapping real-world data. Numerous EMR platforms do not integrate. In some cases, smaller clinics cannot afford major platforms such as EPIC and cling to fax machines and paper-based files.

Yet, innovation can leapfrog over those hurdles. Israel's experts in information technology and cybersecurity can address those barriers. While not as simple as exporting a specific technology, Israeli-based health tech and information innovators often base their approaches not on competing with other products but on a transformational approach that upgrades system operating models.

If communicated in ways that make the complex simple, reducing that current friction has significant implications.

There are solutions out there, developed by Israeli entrepreneurs, that can move the needle. Navina, for example, turns fragmented patient data into a concise patient profile with actionable insights using AI. Briya can tap decentralized, blockchain-secured health data to enable secure, real-time access to longitudinal patient data, accelerating AI-driven life sciences. Phase V can increase the efficiency and effectiveness of drug application in clinical trials. Companies like these bridge care and clinical innovation.

Proof-of-concept steps could inspire health decision-makers to focus more on the possibilities than the obstacles. Preventive medicine and health innovation could move from aspiration to reality. Health-care spending could shift from late-stage intervention to early-stage management. The savings could be redirected to innovation that improves the human condition.

If Israel's innovation leaders want to help and pursue a growth strategy, they will have to support this change in operational ways that work within the U.S. Israel offers a glimpse of what prevention looks like when it works. It must resist the urge to push the U.S. system to adapt to its health system model.

That is difficult for a country that is intense about moving forward, always innovating, constantly asking how things can be done more efficiently, and implementing at speed.

It is an "innovation meets operation" culture clash, even as the two countries appreciate and share the hunger to collaborate and improve people's lives.

The advice to Israeli entrepreneurs is to be clear about where the U.S. system is today and to communicate beyond the "product" and how it works, including how it might transform operational efficiency at the care and cost levels. Illness is always a given. Health is the goal.

The United States seeks to build operational policies and practices to support preventive care. The scale of the country makes change challenging. Israeli innovation and application is a form of developmental laboratory for the States. Along with invention, Israel needs to see itself as increasingly supplying best practice, proven models that make transformation at scale possible.

• Share this page on Facebook
• Share this page on LinkedIn
• Share this page on Twitter

• TAGS:

• Health

POSTED BY: Go'el Jasper